|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 12, 531-534, Copyright © 1997 by European Association for Cardio-thoracic Surgery
A Kir, K Tahaoglu, E Okur and T Hatipoglu
OBJECTIVE: To evaluate the results of resectional surgery as an adjuvant
therapy in multi-drug resistant tuberculosis. METHODS: A total of 27 human
immunodeficiency virus (HIV)-negative patients with multi- drug resistant
tuberculosis underwent resectional surgery between 1993 and 1996. The
lesions were bilateral in 16 cases, with a preponderance of cavities on one
side. Out of 27 cases, 5 patients had unilaterally destroyed lung; 20
patients underwent pneumonectomy (15 left, 5 right). Lobectomy operations
included bilobectomy superior (n = 1), right lower lobectomy (n = 2), right
upper lobectomy (n = 3), and left upper lobectomy with superior
segmentectomy (n = 1). RESULTS: Because of haemorrhage, 2 cases who
underwent a right and left pneumonectomy, respectively, required revision
on the first day . Bronchopleural fistula was found in 2 cases with left
pneumonectomy. Apical residual space was left in one of the 3 patients who
underwent right upper lobectomy. Retreatment protocols resulted in negative
cultures and smears in all patients with an average duration of 4 months
(1-6 months). A total of 4 patients (16%) completed a retreatment period of
18-24 months with negative cultures. Only 1 patient (3.7%) developed
relapse in the 17th month of retreatment. Patients with negative cultures
numbered 22 and continued receiving retreatment. CONCLUSIONS: Our results
indicate that surgical management of multi-drug resistant tuberculosis,
combined with chemotherapy, provides a more favourable outcome than that
obtained with medical therapy alone.
ARTICLES
Role of surgery in multi-drug-resistant tuberculosis: results of 27 cases
Sureyyapasa Center for Chest Diseases and Thoracic Surgery, Istanbul, Turkey.
This article has been cited by other articles:
![]() |
T. Mohsen, A. Abou Zeid, and S. Haj-Yahia Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: A seven-year review of a single institution's experience J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 194 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
L P. Ormerod Role of surgery in pulmonary multidrug-resistant tuberculosis Thorax, May 1, 2007; 62(5): 377 - 377. [Full Text] [PDF] |
||||
![]() |
J. G Somocurcio, A. Sotomayor, S. Shin, S. Portilla, M. Valcarcel, D. Guerra, and J. Furin Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru Thorax, May 1, 2007; 62(5): 416 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kim, C. H. Kang, Y. T. Kim, S-W. Sung, J. H. Kim, S. M. Lee, C-G. Yoo, C-T. Lee, Y. W. Kim, S. K. Han, et al. Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis Eur. Respir. J., September 1, 2006; 28(3): 576 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Adjuvant resectional surgery improves cure rates in multidrug-resistant tuberculosis. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 693 - 696. |
||||
![]() |
S.-i. Takeda, H. Maeda, M. Hayakawa, N. Sawabata, and R. Maekura Current Surgical Intervention for Pulmonary Tuberculosis Ann. Thorac. Surg., March 1, 2005; 79(3): 959 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Souilamas, M. Riquet, F. Le Pimpec Barthes, A. Chehab, A. Capuani, and E. Faure Surgical treatment of active and sequelar forms of pulmonary tuberculosis Ann. Thorac. Surg., February 1, 2001; 71(2): 443 - 447. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |